55 Results for "

MALT

" in MedChemExpress (MCE) Product Catalog:
Products (55)

55 Results for "MALT" in MCE Product Catalog:

  • Targets Recommended:
10
10 Publications Verification
Cat. No.: HY-13599
CAS No.: 4291-63-8
Purity:  99.97%
Synonyms: 2-Chloro-2′-deoxyadenosine; CldAdo; 2CdA
Cladribine (2-Chloro-2′-deoxyadenosine), a purine nucleoside analog, is an orally active adenosine deaminase inhibitor. Cladribine functions as an inhibitor of DNA synthesis to block the repair of the damaged DNA. Cladribine can inhibit DNA methylation. Cladribine has anti-lymphoma activity. Cladribine can be used for the research of several hematologic malignancies and multiple sclerosis .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-12276
CAS No.: 1047953-91-2
Purity:  99.73%
Target:  

MALT1

Research Areas:  

Cancer

MALT1 inhibitor MI-2 is a MALT1 inhibitor (IC50=5.84 μM). MALT1 inhibitor MI-2 binds directly to MALT1, irreversibly suppresses protease function and is accompanied by NF-κB reporter activity suppression, c-REL nuclear localization inhibition, and NF-κB target gene downregulation. MALT1 inhibitor MI-2 shows nontoxic to animals .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-115466
CAS No.: 1832578-30-9
Purity:  99.89%
Target:  

MALT1

Research Areas:  

Inflammation/Immunology

MLT-748 is a potent, selective and allosteric inhibitor of MALT1, binds MALT1 in the allosteric Trp580 pocket, with an IC50 of 5 nM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-139399
CAS No.: 2230273-76-2
Purity:  99.63%
Synonyms: JNJ-67856633
Target:  

MALT1

Research Areas:  

Cancer

Safimaltib (JNJ-67856633) is an orally active, first-in-class, potent, selective and allosteric MALT1 protease inhibitor. Safimaltib in some cases lead to tumor stasis .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-121282
CAS No.: 60-89-9
Purity:  99.91%
Synonyms: Pecazine
Target:  

MALT1 Apoptosis

Research Areas:  

Cancer

Mepazine (Pecazine) is a potent and selective MALT1 protease inhibitor with IC50s of 0.83 and 0.42 μM for GSTMALT1 full length and GSTMALT1 325-760, respectively. Mepazine affects viability of ABC-DLBCL cells by enhancing apoptosis .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-121282A
CAS No.: 2975-36-2
Purity:  99.94%
Synonyms: Pecazine hydrochloride
Target:  

MALT1 Apoptosis

Research Areas:  

Cancer

Mepazine hydrochloride (Pecazine hydrochloride) is a potent and selective MALT1 protease inhibitor with IC50s of 0.83 and 0.42 μM for GSTMALT1 full length and GSTMALT1 325-760, respectively. Mepazine hydrochloride affects viability of ABC-DLBCL cells by enhancing apoptosis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-113011
CAS No.: 1109-28-0
Purity:  ≥98.0%
Maltotriose is a maltooligosaccharide and a specific inducer of the Escherichia coli maltose operon. The oligosaccharide structure of Maltotriose acts as a highly efficient drug delivery carrier, which significantly enhances the targeting ability and water solubility of photosensitizers in photodynamic therapy for pancreatic cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-142648
CAS No.: 1832576-25-6
Purity:  99.49%
Target:  

MALT1

Research Areas:  

Cancer

MLT-985 is a selective allosteric and orally active MALT1 inhibitor with an IC50 value of 3 nM. MLT-985 can suppress cell growth and aberrant CARD11/BCL10/MALT1 complex signaling. MLT-985 can be used for the research of cancer, such as B cell malignancies .
loading...
    loading...
Cat. No.: HY-120231
CAS No.: 1381885-28-4
Target:  

MALT1 NF-κB MMP

Research Areas:  

Cancer

Z-VRPR-FMK is an irreversible MALT1 protein inhibitor. Z-VRPR-FMK inhibits the growth and invasion of diffuse large B-cell lymphoma by inhibiting MALT1-induced NF-κB activation and MMP expression .
loading...
    loading...
Cat. No.: HY-160698
CAS No.: 2661481-41-8
Target:  

MALT1 Apoptosis

Research Areas:  

Cancer

SGR-1505 is an oral small molecule MALT1 inhibitor with anti-proliferative and antitumor activity.SGR-1505 inhibits MALT1 enzymatic activity to modulate NF-κB pathway gene expression.SGR-1505 induces modulation of cell cycle, DNA damage, and apoptosis-related genes in in vivo tumor samples.SGR-1505 exerts tumorostatic and regressive activity in ABC-DLBCL xenograft models.SGR-1505 can be used for the research of activated B cell-like diffuse large B cell lymphoma, non-Hodgkin B-cell lymphomas, chronic lymphocytic leukemia, and mature B cell neoplasms .
loading...
    loading...
Cat. No.: HY-N6723
CAS No.: 116355-84-1
Fumonisin B2 is a selective ceramide synthase inhibitor and carcinogenic mycotoxin with toxicity comparable to that of Fumonisin B1 (HY-N6719). Fumonisin B2 inhibits de novo sphingolipid biosynthesis by blocking the amide bond formation between fatty acids and dihydrosphingosine, which leads to a massive intracellular accumulation of free dihydrosphingosine, altered sphingosine levels, subsequent inhibition of cell proliferation, and induction of cell death. Fumonisin B2 is used to investigate the pathogenesis of diseases associated with Fusarium verticillioides contamination, including equine leukoencephalomalacia, porcine pulmonary edema syndrome, human esophageal cancer, and rat hepatocellular carcinoma .
loading...
    loading...
Cat. No.: HY-P1407
Target:  

MALT1 NF-κB MMP

Research Areas:  

Cancer

Z-Val-Arg-Pro-DL-Arg-Fluoromethylketone TFA is an irreversible MALT1 protein inhibitor. Z-Val-Arg-Pro-DL-Arg-Fluoromethylketone TFA inhibits the growth and invasion of diffuse large B-cell lymphoma by inhibiting MALT1-induced NF-κB activation and MMP expression .
loading...
    loading...
Cat. No.: HY-174371
CAS No.: 3032576-92-1
INNO-220 is an orally active, CRBN-dependent molecular glue degrader targeting CK1α. INNO-220 induces cell cycle arrest at G0/G1 phase and triggers apoptosis by degrading CK1α. INNO-220 disrupts the assembly and function of the CARD11/BCL10/MALT1 complex, thereby inhibiting NF-κB signaling in stimulated T cells and lymphoma cells that harbor an activating mutation in CARD11. INNO-220 provides a new direction for lymphoma research.
loading...
    loading...
Cat. No.: HY-134820
CAS No.: 1832576-04-1
Purity:  99.77%
Target:  

MALT1

Research Areas:  

Inflammation/Immunology

MLT-943 is a potent, selective and orally active MALT1 protease inhibitor. MLT-943 inhibits stimulated-IL-2 secretion in PBMC or in whole blood with a similar IC50 across species (0.07-0.09 μM in PBMC, 0.6-0.8 μM in whole blood). MLT-943 has anti-inflammatory activities and can be used for FcgR-mediated inflammation research .
loading...
    loading...
Cat. No.: HY-W007708
CAS No.: 4412-91-3
3-Furanmethanol, a volatile furan compound, can be detected in malt beverages fermented with Bifidobacterium breve. 3-Furanmethanol exhibits roasty, popcorn-like flavors .
loading...
    loading...
Cat. No.: HY-158361
Malt extract can be used as a nutrient source for culture media. Malt extract is a kind of biological materials or organic compounds that are widely used in life science research .
loading...
    loading...
Cat. No.: HY-124587
CAS No.: 2097853-86-4
Purity:  99.56%
Target:  

MALT1

Research Areas:  

Inflammation/Immunology

MLT-747 is a potent, selective, allosteric inhibitor of MALT1, binds MALT1 in the allosteric Trp580 pocket, with an IC50 of 14 nM .
loading...
    loading...
Cat. No.: HY-173097
CAS No.: 2086298-33-9
Synonyms: VH032-Boc derivative 1
Target:  

MALT1

Research Areas:  

Cancer

(S,R,S)-AHPC-Boc derivative 1 (Compound 80-9; VH032-Boc derivative 1) is a selective proteasomal degrader targeting MALT1, which recruits the E3 ubiquitin ligase CRBN to form a ternary complex with MALT1, leading to ubiquitination and subsequent proteasomal degradation of MALT1. (S,R,S)-AHPC-Boc derivative 1 inhibits the NF-κB signaling pathway by disrupting the CBM complex, demonstrating potential for inducing apoptosis in ABC-DLBCL cells. (S,R,S)-AHPC-Boc derivative 1 is promising for research of MALT1-dependent cancers, such as diffuse large B-cell lymphoma (DLBCL) .
loading...
    loading...
Cat. No.: HY-151805
CAS No.: 2577171-33-4
Target:  

MALT1

Research Areas:  

Inflammation/Immunology

RGT-068A is a MALT1 inhibitor with oral bioavailability. RGT-068A inhibits MALT1 activity. RGT-068A can be used for the research of autoimmune diseases .
loading...
    loading...
Cat. No.: HY-177117
CAS No.: 2434602-26-1
Target:  

MALT1

Research Areas:  

Infection Neurological Disease Cancer

Ocipumaltib (Example 2) is an inhibitor of mucosa associated lymphoid tissue protein 1 (MALT1). Ocipumaltib is an antitumor agent. Ocipumaltib can be studied in research for cancer, infection, neurological and hematological diseases .
loading...
    loading...